# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $3.5 to $3...
https://www.marijuanamoment.net/trump-endorsing-florida-marijuana-legalization-initiative-would-guarantee-victory-top-ally-roge...
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 25 per...